Following TRUS biopsy 75 men were subsequently diagnosed with prostate cancer (median age 64 years, median PSA 7.4 μg/L) and 27 had a benign histological finding (median age 65 years, median PSA 7.45 μg/L). This evidence concerns the gene KLK3 and prostate cancer.